Synapse

← Jurriën M. ten Berg

Papers by Jurriën M. ten Berg

Page 6 · newest first

  1. The influence of residential distance on time to treatment in ST-elevation myocardial infarction patientsNetherlands Heart Journal · 2014
  2. Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: Rationale and designEuropean Heart Journal Acute Cardiovascular Care · 2014
  3. 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Journal of Cardio-Thoracic Surgery · 2014
  4. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)European Heart Journal · 2014
  5. Open Transapical Approach to Transcatheter Paravalvular Leakage ClosureCirculation Cardiovascular Interventions · 2014
  6. Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathyHeart · 2014
  7. Aspirin Therapy in Primary Cardiovascular Disease PreventionJournal of the American College of Cardiology · 2014
  8. Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trialEuropean Heart Journal · 2014
  9. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trialEuropean Heart Journal · 2014
  10. The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery diseaseThrombosis and Haemostasis · 2014
  11. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stentingThrombosis and Haemostasis · 2014
  12. Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarctionThrombosis and Haemostasis · 2014
  13. Bivalirudin Started during Emergency Transport for Primary PCINew England Journal of Medicine · 2013
  14. Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary SyndromesNew England Journal of Medicine · 2013
  15. Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomyNetherlands Heart Journal · 2013
  16. Prehospital Treatment of ST-segment Elevated Myocardial Infarction PatientsFuture Cardiology · 2013
  17. A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patientsEuroIntervention · 2013
  18. Pre-hospital diagnosis, triage and treatment in patients with ST elevation myocardial infarctionHeart · 2012
  19. Left Bundle-Branch Block Induced by Transcatheter Aortic Valve Implantation Increases Risk of DeathCirculation · 2012
  20. Thrombo-Embolism and Antithrombotic Therapy for Heart Failure in Sinus Rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on ThrombosisENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2012
  21. The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stentingPharmacogenetics and Genomics · 2012
  22. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythmThrombosis and Haemostasis · 2012
  23. The effect of pre‐hospital glycoprotein IIb–IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCICatheterization and Cardiovascular Interventions · 2011
  24. Coronary stent thrombosis: incidence, predictors and triggering mechanismsInterventional Cardiology · 2011
  25. Effect of gender difference on platelet reactivityNetherlands Heart Journal · 2011
  26. Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysisBMJ · 2011
  27. Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delayEuroIntervention · 2011
  28. Comparison of outcome after patent foramen ovale closure in older versus younger patientsEuroIntervention · 2011
  29. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathyAJP Heart and Circulatory Physiology · 2011
  30. Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?Netherlands Heart Journal · 2011
  31. Triggering mechanisms of stent thrombosisEuroIntervention · 2011
  32. The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarctionThrombosis and Haemostasis · 2011
  33. Percutaneous Atrial Shunt Closure Using the Novel Occlutech Figulla Device: 6‐Month Efficacy and SafetyJournal of Interventional Cardiology · 2010
  34. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trialEuropean Heart Journal · 2010
  35. Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adultsEuroIntervention · 2010
  36. High-dose tirofiban pretreatment reduces the need for bail-out study medication in patients with ST-segment elevation myocardial infarction: results of a subgroup analysis of the On-TIME 2 trialHeart · 2010
  37. Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapyHeart · 2010
  38. CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control studyEuropean Heart Journal · 2010
  39. The BioSTAR(r) device versus the CardioSEAL(r) device in patent foramen ovale closure: comparison of mid-term efficacy and safetyEuroIntervention · 2010
  40. A single dose of erythropoietin in ST-elevation myocardial infarctionEuropean Heart Journal · 2010
  41. Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trialEuroIntervention · 2010
  42. Platelet function tests for the monitoring of P2Y12 inhibitorsExpert Opinion on Medical Diagnostics · 2010
  43. Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent ImplantationJAMA · 2010
  44. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-responseThrombosis and Haemostasis · 2010
  45. Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantationPharmacogenetics and Genomics · 2009
  46. Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closureClinical Physiology and Functional Imaging · 2009
  47. Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trialsEuropean Heart Journal · 2009
  48. Common Variation in the Platelet Receptor P2RY12 Gene Is Associated With Residual On-Clopidogrel Platelet Reactivity in Patients Undergoing Elective Percutaneous Coronary InterventionsCirculation Cardiovascular Genetics · 2009
  49. Is a predominant left‐to‐right shunt associated with migraine?: A prospective atrial septal defect closure studyCatheterization and Cardiovascular Interventions · 2009
  50. Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent ThrombosisCirculation · 2009